Epidermal barrier represents the first line of defense against a variety of external insults and its disruption is involved in common inflammatory skin diseases, including psoriasis, contact and atopic dermatitis. Despite a growing interest in skin barrier abnormalities, few studies permit to follow the barrier repair mechanisms. Here we present a new integrated approach to understand skin barrier recovery after physical (tape stripping, TS) or chemical (SDS) injury by combining human skin organ culture and Reflectance Confocal Microscopy (RCM). TS in vitro produced a complete removal of stratum corneum and lipids, a drastic decrease of structural and adhesion proteins, and an increase in cell proliferation. Epidermal recovery with either proliferation or differentiation rescue was observed after 18 hours, with no apoptotic cell detection. On the other hand, when skin organ cultures were exposed to 2% SDS, cellular junctions were disrupted and the expression of late differentiation markers decreased. Junctions repair was detected 24 hours after treatment, with the restoration of epidermal integrity. Both models (TP or SDS) showed the induction of immuneinflammatory markers, such as psoriasin, keratin 16, and the increase in Langerhans cell number.
Corneodesmosomes hold keratinocytes together, and undertake a gradual degradation process leading to desquamation (2) . Adherents and tight junctions contribute to barrier functions, by mediating intercellular stability, protecting the organism from the outside and by preventing water loss (3).
Barrier alteration is associated with desquamation, loss of corneocyte cohesiveness and extracellular lipids content, increasing transepidermal water loss (TEWL) and skin dehydration (4) . Upon artificial barrier disruption, basal keratinocyte proliferative kinetics is accelerated in mice (5, 6) , and the delicate balance between cornification and desquamation is temporarily altered, resulting in hyperkeratosis and parakeratosis (7). However, the knowledge regarding the mechanisms underlying the repair of the barrier is still sparse and incomplete.
Experimentally disrupted skin barrier is extensively used not only to study epidermal regeneration after injury, but also to quantify topical and transdermal drug penetration (8) or to evaluate drug bioavailability and bioequivalence. Experimental methods to perturb permeability barrier include tape stripping (TS), as a mechanical approach of SC removal (9), and the application of irritant and/or chemical substances on the skin surface in vivo, such as acetone, detergents, sodium dodecil sulphate (SDS) (4) . Initial in vitro studies were mostly focused on biochemical assessments, such as TEWL or pH determination (10). In addition, to avoid subjecting patients to unnecessary discomfort and risk, the experimental damage induction in humans must be mild and poorly invasive (11).
However, this approach only partially alters or removes the SC, therefore limiting the studies on barrier perturbation. Several studies were performed in animal models such as mice, dog and pig (12, 13, 14) , although results must take into account the interspecies difference (15, 16). Recently, RCM aspects of dry skin and changes occurring during the hydration given by moisturizers showed the applicability of this technique to in vivo monitoring of morphological variations of keratinocytes and inter-keratinocyte junctions related with skin barrier function (32).
Given that common inflammatory skin diseases (e.g. psoriasis and atopic dermatitis) show skin barrier abnormalities (33), the study of skin barrier recovery is of great value.
Here, we used in vivo human skin organ culture models to disrupt skin barrier through TS or SDS exposition. We demonstrate that our systems faithfully reproduce in vivo conditions of barrier perturbation and repair, showing a gradual and slow return to normal proliferation and differentiation over time. In addition, RCM accurately correlates with morphological and functional aspects obtained by traditional techniques. The combination of skin organ cultures and RCM offers a new exciting approach to study in vitro barrier perturbation by testing the efficacy of barrier repair drugs and allowing the execution of fast, non invasive toxicological studies. 
MATERIAL AND METHODS

Skin organ culture model of barrier perturbation by tape stripping (TS) or SDS treatment
Skin organ cultures were generated by 8mm-punch biopsies from healthy skin obtained from waste materials from Operating Roomby. Patient consent for experiments was not required because Italian laws consider human tissue left over from surgery as discarded material. For the TS model, 40, 60 and 100 repeated 3M adhesive tape applications and removal were applied on total skin to remove SC (Fig. S1 ). Biopsies were maintained in air-liquid interface and analyzed at different time points after TS treatment (0, 18, 24 and 36 hours). For the SDS model, organ culture were treated with 2% SDS and incubated at 4°C for 18 hours, before starting culturing in air-liquid interface (Fig. S1 ).
They were analyzed at different time points after SDS treatment (0, 18, 24 and 36 hours). For both models, the longest time point untreated air-liquid cultured skin biopsy was used as control.
Epidermal thickness was measured by ImageJ software. In addition, TS model was further tested by the application of a barrier recovery cream on skin organ cultures immediately after TS treatment, and the barrier repair was analyzed 18 and 24 hours later. The experiments were done in triplicate and results are displayed as mean +/-SD.
Red oil O staining
Skin organ culture cryosections were dried at room temperature and fixed in ice cold 10% formalin for 5 minutes. After 5 minutes incubation in absolute propylene glycol, slides were stained in prewarmed Oil Red O solution (Sigma, St. Louis, MO, USA) for 10 minutes at 60°C, differentiated in 85% propylene glycol solution and counterstained with Mayer's hematoxylin for 30 seconds. The images are representative of three independent experiments.
Immunohistochemistry
Skin organ culture sections from formalin fixed-paraffin blocks were stained using the UltraVision LP Detection System AP Polymer & Fast Red Chromogen assay (Thermo Fisher Scientific), Page 6 of 33   1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49  50  51  52  53  54  55  56  57  58  59  60   F  o  r  R  e  v  i  e  w  O  n  l  y   7 according to the manufacturer's instructions. Briefly, slides were treated with Ultra V Block and samples were incubated with polyclonal rabbit anti-loricrin (1:500 Abcam) or monoclonal mouse anti-filaggrin (1:50, Abcam); or polyclonal rabbit anti-claudin 1 (ready to use, Abcam), or monoclonal rabbit anti-ki67 (1:100, Epitomics), or monoclonal rabbit anti-P-Stat3, mouse antikeratin 16, polyclonal rabbit anti-psoriasin, monoclonal rabbit anti-CD1a (ready to use, Ventana) for 1 hour at room temperature. After washes in PBS, Primary Antibody Enhancer (Thermo Fisher Scientific) was added for 20 minutes at room temperature, followed by incubation with AP Polymer anti-mouse/rabbit IgG for 30 min at room temperature. Slides were stained with Fast Red using Naphthol Phosphate as substrate. Samples were analyzed under a conventional optical microscope (Zeiss Axioskope 40). The results were scored according to entities and intensity of expression: -not expressed; + poorly expressed; ++ moderatly expressed; +++ well expressed. The images are representative of three independent experiments.
Immunofluorescence
Skin organ culture sections from formalin fixed-paraffin blocks were blocked with a 0,5% BSA/ 5% goat serum solution for 15 minutes. Slides were then incubated for 1 h at 37°C with polyclonal rabbit anti-claudin 1 (1:100, Abcam) or anti-desmoglein 1 (1:100; Santa Cruz). The corresponding TRITC-conjugated secondary antibodies were added in the dark for 45 minutes at room temperature and were analyzed by confocal microscopy (Leica TCS SP2; Leica, Heerbrugg, Switzerland). The images are representative of three independent experiments.
Western Blotting
Total proteins were extracted with RIPA lysis buffer containing protease inhibitors. Equal amount of protein from each sample was run through a 10-15% SDS-PAGE gel and transferred onto a nitrocellulose membrane. Briefly, membranes were first incubated in blocking buffer and then overnight at 4°C with the following primary anti-human antibodies: polyclonal rabbit anti-caspase 3 
RESULTS
Stratum corneum recovering after complete barrier removal by TS
To ensure a complete SC elimination, we performed a variable number of tape applications (40, 60 and 100) onto total skin from different age and anatomic sites derived from surgical waste and evaluated the epidermal thickness at different time points after skin organ culture (0, 18, 24 and 36 hours) (Fig. S2a,b,c) . 100 times of tape repeated applications resulted in barrier disruption, characterized by complete SC removal, as shown by H&E staining (Fig. S2a,b) . Indeed, 18 hours after TS, SC started recovering the underneath layers, with a progressive increase in the epidermal thickness that become close to the un-stripped control at 36 hours (Fig. 2c ). Therefore, for subsequent studies, we used the TS model with 100 strips, which eliminate the SC without causing apparent morphological alterations of the remaining skin layers.
Intercellular lipid component, known as important regulator of skin permeability (35), was entirely removed after TS treatment, and its regeneration was still undetectable at 36 hours, as shown by Red Oil O dye (Fig. 1a,b ). Filaggrin and loricrin, two major proteins expressed in the intact horny layer (36), were markedly impaired after TS. Filaggrin was still poorly detectable 18 hours later, but started to be moderately re-expressed at 24 hours. On the contrary, appreciable levels of loricrin were already detectable at the first time point (Fig. 1a,b ).
TS skin application provokes cell-cell junction alteration (37). Therefore, we examined this aspect through the analysis of claudin, a tight junctions-forming protein that is homogeneously expressed in the stratum granulosum (SG). After TS, claudin pattern expression appeared discontinuous and irregular, while it started to reconstitute after 24 hours, reaching levels similar to control at 36 hours (Fig. 1a,b) .
By looking more in detail at the differentiation markers, we found that filaggrin expression increased over time, showing higher amounts compared to the untreated control, starting from 18 hours. Involucrin slightly decreased after TS and started to increase at 18 hours. At 24 hours, both filaggrin and involucrin expression was higher than controls ( Fig. 1c,d ). With a similar profile, the adhesion molecule desmoglein 1 (Dsg1) was markedly reduced after TS and overexpressed during barrier recovery at 18 and 24 hours as compared to control (Fig. 1c,d ).
Increased keratinocyte proliferation during barrier recovery after TS treatment
It has been previously shown that murine barrier perturbation by TS stimulates keratinocyte proliferative kinetics and epidermal hyperplasia (6) . To evaluate if the barrier recovery was associated with proliferation or hyperplastic response in our model, we evaluated Ki67 expression and Stat3 phosphorylation (P-Stat3), respectively, at different time points after TS. Interestingly, skin organ cultures responded to barrier damage by increasing proliferation (Fig. 1a) . Indeed, they highly expressed Ki67 with a peak at 18 hours post TS when compared to the untreated controls ( Fig. 1e ). P-Stat3 positive cells were around 100 fold more numerous than in the untreated controls at 18 hours ( Fig. 1e ) and remained persistently active even at later time points, while Ki67 expression was progressively normalized.
We also addressed if TS-related damage induced keratinocyte apoptosis by TUNEL assay. Few apoptotic cells were detected in the epidermis immediately after TS at 18 hours, most likely due to the presence of parakeratosis caused by the treatment and the activation of terminal differentiation enzymes (38) (Fig. S3a) . On the other hand, no dead cells were present at later time points and this result was confirmed by the absence of caspase-3 activation after TS (Fig. S3b) .
RCM reveals morphological aspects of skin and barrier repair in TS model
To better define skin barrier recovery after TS, we evaluated skin organ culture morphology by RCM, as integrated imaging technology to analyze barrier perturbation models in vitro. The acquisition of a series of 3 consecutive sequences of images reaching 150 µm depth showed that, immediately after TS, skin organ culture was thinner than control (technical data) and cell contours displayed an irregular pattern, as sign of structural alteration (Fig. 1f) . In details, corneocytes were reduced and the honeycombed pattern of the granulosum layer was visible in the upper images. At 1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49  50  51  52  53  54  55  56  57  58  59 18 hours, corneocytes returned to a well defined pattern, while the spinous and granular layer became thicker, thus indicating reactive proliferation. 24 hours after TS, cell contours appeared brighter, most likely because of the intense metabolic activity in response to the barrier damage.
Finally, at 36 hours, SC was clearly visible, showing the presence of normal corneocytes with multiple cell layers, and its maturation was almost complete. We also examined the effect of a moisturizing cream for barrier recovery on the SC repair, as compared to its vehicle. At 18 hours, drug application induced a more evident increase of epidermal thickness, as compared to the untreated TS model (Fig. 2a,b) . Furthermore, claudin and filaggrin were re-expressed at 18 hours only in treated TS models (Fig. 2a,c) . At 24 hours, epidermal thickness, claudin and filaggrin expression reverted to normal control only upon drug application (Fig. 2a,b,c) . RCM confirmed the barrier restoration and the activity of the drug that promotes skin regeneration (Fig. 2d) . While 18 hours after TS control, skin surface displayed a homogeneus pattern with only few visible mature corneocytes, in the presence of the drug, the corneocytes appeared larger, with a cytoplasm enriched in organells (that correlate with cell brightness), which are clear examples of recovery activity. At 24 hours cell contours became thicker and cells appeared to be bigger, as compared to untreated samples.
Skin barrier disruption by SDS alters cell-cell adhesion and terminal differentiation
To better elucidate the molecular mechanism involved in barrier repair after chemical damage, we exposed the organ cultures from healthy human skin to 2% SDS solution for 18 hours, and analyzed the samples at different time points. Although SDS treatment fail to remove SC, skin barrier defects were demonstrated by the altered expression of Dsg1 and by claudin (Fig. 3a,b) . 18 hours after SDS exposure, skin organ cultures re-expressed claudin and Dsg1 in a homogeneous pattern, which became similar to control at 24 hours. By western blot analysis, claudin, filaggrin and Dsg3 were strongly reduced after SDS treatment and were restored over time (Fig. 3c,d ). 1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49  50  51  52  53  54  55  56  57  58  59 
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Proliferation increases during barrier recovery after SDS-induced damage
To address if SDS treatment induces keratinocytes apoptosis, we performed TUNEL assay.
Similarly to TS, SDS application does not induce DNA fragmentation at all time points (Fig. S4a) .
Moreover, activated caspase-3 was not detected by western blot analysis (Fig. S4b) . On the other hand, we observed a strong keratinocyte tendency to proliferate after SDS-induced damage (Fig.   3e ). In particular, immediately after SDS treatment, the expression levels of Ki67 and P-Stat3 were respectively 3-fold and 42-fold more than the untreated controls (Fig. 3f) . At 18 hours, Ki67 and PStat3 positive cell number showed a peak that progressively decreases in a time-dependent manner up to 36 hours.
RCM reveals morphological and functional aspects of barrier repair in SDS model
After SDS treatment, RCM revealed increased brightness of superficial layers and decreased interkeratinocyte brightness, suggesting a toxic damage to keratinocytes (Fig. 3g) (29) . 18 and 24 hours after treatment, nuclei appeared pyknotic, while cell contours and junctions were poorly delineated. In particular, keratinocytes appeared detached from each other at 24 hours, and cell damage, corresponding to small bright polygonal keratinocytes (34) was found in the deeper layers.
Conversely, cell shapes did not change significantly after 36 hours.
Skin barrier recovery after SDS or TS mimics inflammatory skin disease features
We also wanted to assess the immune response and cell activation consequent to barrier disruption.
In human epidermis, LCs are in situ dendritic cells involved in immune functions and are characterized by the expression of CD1a (39) and other markers (40). SDS or TS induced a substantial increase in LCs starting from 18 hours post treatment (Fig. 4a,b,d,e) . Similarly, keratinocytes displayed an "activation profile" typical of response to injuries or inflammatory skin 25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49  50  51  52  53  54  55  56  57  58  59 (Fig. 4a,c,d,f) . Indeed, keratin 16 expression is induced in hyperkeratotic lesions as well as in atopic dermatitits or psoriasis (41), and it is has been recently shown to play a specific role in the regulation of immune response (42). Psoriasin, also indicated as S100A7, is overexpressed in hyperproliferative skin diseases, where it not only exhibits antimicrobial functions, but also induces immunomodulatory activities, including chemotaxis and cytokine/chemokine production (43). Therefore, these data indicates that our model can recapitulate the behavior of immune-inflammatory molecules in the context of skin conditions characterized by barrier disruption. 25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49  50  51  52  53  54  55  56  57  58  59 
DISCUSSION
The alterations of the cornified layer imply barrier defects, including the transepidermal water loss (TEWL), dehidratation, desquamation and loss of lipids contents, which are all found in several inflammatory skin diseases, such as atopic dermatitis and psoriasis (44). Given the frequency of such conditions (45, 46) and the necessity of ethical studies always closer to human skin physiology, it is important to have models that faithfully reproduce skin barrier defects. Indeed, they allow to elucidate several parameters, such as drug kinetic and penetration, infections and barrier repair after injuries.
Here, we investigated the ex-vivo skin barrier recovery by human skin organ cultures after acute barrier disruption achieved by physical or chemical treatment: tape stripping (TS), that physically removes the cornified layer, and SDS (sodium-dodecil-sulfate) application, which is known to be harsh on the SC and induces skin damage. Although these methods are widely used in vivo, the knowledge regarding the molecular mechanisms underlying barrier repair is still insufficient and sometimes controversial. Human in vivo studies often require mild aggression for ethical reasons and the results are frequently inconclusive because of a response with low significance, due to the absence of a real alteration of barrier function (4). On the other hand, barrier restoration studies are usually performed on transgenic animal models, which somehow show higher variability when compared to humans. Therefore, in the present work, we analyze an alternative method to study skin barrier functionality by using in vitro models only. Moreover, the application of RCM confirms the feasibility of this innovative technique and the potential application in pharmacological studies regarding skin pathologies together with toxicological studies.
Our models allow maintaining human skin features in vitro, thus overcoming the inter-species variability. Our data report that both TS and SDS models applied on skin organ culture, recapitulate Skin mechanical resistance is ensured by a scaffold of structural components, proteins involved in epidermal terminal differentiation and lipids (36). It has been established that the acute barrier perturbation induces a transitory reduction of the calcium levels in the stratum granulosum that lead to lower levels of involucrin, loricrin and profilaggrin (7). Our models confirmed that skin barrier disruption, either chemically or mechanically induced, involved both terminal differentiation protein alterations, such as involucrin, filaggrin, loricrin, and lower expression of intercellular junctions mediators, such as claudin and desmoglein. Indeed, after skin barrier disruption, there is a temporary imbalance between cornification and desquamation (47). This phenomena results in hyperkeratosis and parakeratosis, which ensure a rapid skin barrier repair (7), and act as regulatory mechanism that in turn stimulates basal layer proliferative kinetics (5). We observed not only high expression levels of Ki67, but also skin hyperplasia after injury. The presence of inflammatoryrelated marker modulation renders both TS and SDS models suitable for the study of the effect of immunomodulatory drugs in the context of skin barrier defects. 1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49  50  51  52  53  54  55  56  57  58  59 of corneocyte (probably for cytoplasmic clotting/cohartation) was visible immediately after, whereas appearance of bright basal keratinocytes, correlated with cytological damage and necrosis, was an 18-24 hours delayed event. Interestingly, the morphological changes documented by means of RCM were correlated with the immunohistochemical dynamics, suggesting the added value of a non-invasive technology to study the events occurring in an in vitro model. This means a faster approach that can be used as first non-invasive screening. Moreover, thanks to the knowledge obtained from the study of in vitro models, the morphological changes observed by means of RCM can be exported and compared to in vivo models, in order to gain more specific and biomolecular correlated information during clinical tests of skin topical products.
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